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A  20-year-old female presented with a painless progressively increasing mass in the right hypochondrium of 3-month duration. On examination, 
an 8 cm × 3 cm (transverse, vertical dimension) parietal mass 
was palpable in the right hypochondrium. The lump was non-
tender, firm, and having smooth surface. The lump became less 
prominent on Valsalva maneuver. The upper border was not 
reachable while the lower margin could be appreciated about 
3 cm below the costal margin.
Contrast-enhanced computed tomography (CECT) abdomen, 
and lower thorax revealed a homogenous 8 cm × 7.3 cm × 3 cm 
mass arising from the anterolateral aspect of right lower 7th and 
8th intercostal muscles in the mid-clavicular line. The tumor was 
showing minimal peripheral vascular enhancement (Fig. 1). The 
ultrasound-guided fine-needle aspiration cytology of the mass 
was inconclusive.
Complete excision of the mass was planned on the basis of 
CECT findings. Right subcostal incision was made. The mass 
was found to be arising beneath the right costal margin and 
bulging into peritoneal cavity (Fig. 2). Wide en bloc excision 
of the tumor with extraperiosteal segmental resection of ribs 
and diaphragm was carried out and sent for the histopathology 
(Fig. 3). The immunohistochemical (IHC) analysis was positive 
for Vimentin, smooth muscle actin, beta-catenin, and negative for 
S-100 P, CD-34, and membrane antigen. Ki-67 nuclear protein 
was positive <1%. Post-operative period was uneventful, and the 
patient discharged on the 6th post-operative day.
QUESTIONS
1. What can be the diagnosis?
2. What should be the next plan of management in this patient?
Figure 1: Contrast-enhanced computed 
tomography scan of abdomen axial view 
suggested a 8 cm × 7.3 cm × 3 cm (transverse, 
longitudinal and anteroposterior 
dimension) cm homogenous mass from the 
anterior abdominal wall extending beneath 
the right subcostal region. No clear plane 
was identified between mass and 3 lowest 
ribs anteriorly in mid clavicular line. The 
tumor showed mild peripheral vascular 
enhancement
Figure 2: Peroperative photograph showing 
(a) mass protruding beneath the right 
costal margin (b) exposed ribs (c) after 
excision of mass tumor bed is shown with 
diaphragm margins, (d) excised sp ecimen 
with resected ribs
d
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Figure 3: (a) Sweeping fascicles of spindle 
fibroblast separated by collagen within which 
are scattered thin walled ecstatic vessel, 
(H and E, ×40), (b) spindled fibroblasts and 
myofibroblasts with bland nuclei having 
tapered ends, very rare atypical mitosis, 
and foci of myxoid stromal change. Few 
perivascular lymphocytes and mast cells are 
present (H and E ×100)
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ANSWER 1
The differential diagnosis of lower thoracic wall lump includes 
abdominal muscle hematoma, lipoma, liposarcoma, fibroma, 
fibrosarcoma, lymphoma, rhabdomyosarcoma, neurofibroma, and 
primitive neuroectodermal tumor. This was the case of desmoids 
tumor. The diagnosis was settled through histopathology and IHC 
analysis of the specimen.
Worldwide approximately 3.7 new cases of desmoids occur per 
1 million persons per year [1]. The exact prevalence of desmoids 
tumor in India is still unknown. Desmoid tumors are also known 
as aggressive fibromatoses or low-grade fibrosarcoma [1,2]. 
Desmoids can occur in extremities (around limb girdles or 
proximal extremity), abdominal wall, in the bowel wall and 
mesentery. Patients with abdominal wall desmoids may have a 
prior history of abdominal surgery, trauma, pregnancy, estrogen 
therapy, familial adenomatous polyposis, and Gardner syndrome. 
The desmoids involving lower thoracic wall, and presenting as 
the right hypogastric lump is a rare entity.
Ultrasonography of desmoid tumor may show well-defined 
lesions with varying echogenicity [3]. The CECT appearance 
of desmoid may be hypo-, iso-, or hyper-intense (depending 
on their composition). The appearance may be homogeneous 
or heterogeneous as compared to attenuation of muscles [3]. 
Definitive diagnosis of desmoids can only be ascertained with 
histopathological examination [4].
Answer 2
Desmoid tumors are slow-growing benign tumors. Wide local 
excision is the first line of the management; however, these locally 
aggressive tumors have an increased potential for local recurrence 
despite adequate surgical excision [1]. The reported mortality 
rate from direct invasion of vital organs approaches 10%. Hence, 
periodic follow-up is mandatory in these patients. Recurrent 
tumors are preferably managed by re-excision of the tumor. 
Local adjuvant external beam radiation therapy in combination 
with chemotherapy can be offered to patients not consenting for 
revision wide local excision [5]. Pharmacological agents such 
as anti-estrogen therapy, cyclic-aminophylline (theophylline, 
chlorothiazide, ascorbic acid, and testolactone), warfarin, 
vitamin K-1, or prostaglandin inhibition (clinoril/sulindac) have 
been attempted with a variable degree of success [3].
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